Skip to content

Superior Capsular Reconstruction Using Biceps Augment Graft Versus Tensor Fascia Lata in Young Patients With Irreparable Massive Rotator Cuff Tears: A Randomized Controlled Trial

Superior Capsular Reconstruction for Treatment of Massive Irreparable Rotator Cuff Tears

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202512898489060
Enrollment
40
Registered
2025-12-24
Start date
2023-01-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopaedics

Interventions

Superior Capsular Reconstruction Using Tensor Fascia Lata autograft
Superior Capsular Reconstruction Using Biceps Augment Graft

Sponsors

Benha University Faculty of medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Age between 19 and 45 years Irreparable massive posterosuperior rotator cuff tear confirmed intraoperatively Goutallier grade =2 fatty infiltration of supraspinatus and/or infraspinatus Tendon retraction to or medial to the glenoid rim (Patte stage 3) Failure of nonoperative treatment for at least 6 months Intact or repairable subscapularis tendon Ability to comply with postoperative rehabilitation and follow-up schedule Provided written informed consent

Exclusion criteria

Exclusion criteria: Previous surgery on the affected shoulder Subscapularis tear requiring repair or irreparable subscapularis Advanced glenohumeral osteoarthritis (Hamada grade =3) Rheumatoid arthritis or inflammatory arthropathy Shoulder infection or systemic infection Neuromuscular disorders affecting shoulder function Rotator cuff arthropathy requiring reverse shoulder arthroplasty Massive anterior cuff deficiency Inability to comply with rehabilitation or follow-up Contraindications to anesthesia or surgery

Design outcomes

Primary

MeasureTime frame
Change in American Shoulder and Elbow Surgeons (ASES) score from baseline to 24 months postoperatively.

Secondary

MeasureTime frame
VAS pain during activity.

Countries

Egypt

Contacts

Public ContactMoustafa El Gafary

Medical doctor

moustafak.elgafary@hotmail.com+201061883839

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026